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RNA and DNA are simple linear polymers consisting of only four major types of subunits, and yet these
molecules carry out a remarkable diversity of functions in cells and in the laboratory. Each newly discovered
function of natural or engineered nucleic acids enforces the view that prior assessments of nucleic acid func-
tion were far too narrow and that many more exciting findings are yet to come. This Perspective highlights
just a few of the numerous discoveries over the past 20 years pertaining to nucleic acid function, focusing
on those that have been of particular interest to chemical biologists. History suggests that there will continue
to be many opportunities to engage chemical biologists in the discovery, creation, and manipulation of
nucleic acid function in the years to come.DNAmakes RNAmakes protein. This is the shorthand version of
Francis Crick’s ‘‘central dogma’’ of biology, which more specif-
ically states, ‘‘The transfer of information from nucleic acid to nu-
cleic acid, or from nucleic acid to protein may be possible, but
transfer from protein to protein, or from protein to nucleic acid
is impossible’’ (Crick 1958). Crick was referring to information
that defines the precise sequence of residues within a nucleic
acid or protein. He confessed at the outset of that 1958 paper,
‘‘[James] Watson said to me, a few years ago, ‘The most signif-
icant thing about nucleic acids is that we don’t know what they
do.’’’ Yet in that same paper, Crick proposed that RNA does
muchmore than serve as a passive carrier of information. He hy-
pothesized that it functions as an ‘‘adaptor’’ molecule, carrying
amino acids to the RNA template that directs the sequential as-
sembly of amino acids to form proteins. He suggested that there
would be (at least) one adaptor for each of the 20 amino acids,
although he felt that the task of joining the adaptor to its amino
acid would be too challenging for RNA.
Crick’s adaptor is of course tRNA, which he later said ‘‘looks
like Nature’s attempt to make RNA do the job of protein’’ (Crick
1966). Crick went further to say, ‘‘It is tempting to wonder if the
primitive ribosome could have been made entirely of RNA,’’
and he suggested, ‘‘Possibly the first ‘enzyme’ was an RNA
molecule with replicase properties’’ (Crick 1968). Similar com-
ments regarding the catalytic potential of RNA also were made
at that time by Woese (1967) and Orgel (1968). When Chemistry
& Biology published its introductory issue in 1994, the modern
ribosome was looking very much like an RNA enzyme (Noller
et al., 1992), although that was still to be proved definitively on
the basis of examination of its X-ray crystal structure (Nissen
et al., 2000). RNA enzymes had been discovered in nature
(Kruger et al., 1982; Guerrier-Takada et al., 1983) and invented
in the laboratory through test-tube evolution (Bartel and Szostak,
1993), but even a rudimentary form of a replicase was many
years away (Lincoln and Joyce, 2009).
Certainly one of the most dramatic developments in chemical
biology over the past 20 years has been the growing apprecia-
tion of the many complex functional roles that RNA plays inChemistry & Biology 2biology and can be made to play in chemical systems. Even
DNA can get into the act of ligand binding and enzymatic func-
tion. The central dogma still holds, but nucleic acids are much
more than carriers of information. They are both egg and
chicken, and we still don’t know all that they can do.
Revealing the ‘‘Dark Matter’’ of Biological RNAs
For decades, biologists seemed content to know that there are
messenger, transfer, ribosomal, and a limited number of other
RNAs in biology. Then reports of the first ribozymes (Kruger
et al., 1982; Guerrier-Takada et al., 1983) hinted that the com-
munity was aiming far too low when estimating the range of
functional RNAs in extant organisms. Today, more than 30
years after the discovery of catalytic RNA, it is difficult to over-
estimate the role of RNA in biology. Complete genome
sequencing has provided a more comprehensive view of the
portion of genomes that gives rise to mRNAs, even if some
confusion remains about just what constitutes a translation-
worthy segment of RNA. With many annotated genomes in
hand, one can look to the nucleotide sequences outside the
protein-coding regions for possible transcribed RNAs and puz-
zle over what these noncoding RNAs (ncRNAs) actually do.
Similarly, RNA transcriptomics studies have yielded large col-
lections of transcribed RNAs that apparently do not code for
proteins. Is this mountain of RNAs merely junk, or are there
some valuable molecules in the heap?
The strong evolutionary pressure to minimize waste in bacterial
and archaeal genomes can be exploited by researchers to dis-
cover biologically relevant ncRNAs. There is little wasted space,
so a gap in protein coding strongly suggests the existence of an
important ncRNA. The functions of these RNAs are diverse, going
far beyond tRNAs, rRNAs, and the known ribozymes. Among the
most common of the ncRNAs are short RNA transcripts (sRNAs)
that form complementary pairs with the UTRs of certain mRNAs
and affect gene expression (Waters and Storz, 2009). Clustered
regularly interspaced short palindromic repeat (CRISPR) RNAs
are a fascinating example of sRNAs that are enzymatically pro-
cessed and function as viral- or plasmid-targeting systems to1, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1059
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Sontheimer, 2010).
Some bacterial ncRNAs function not by formingWatson-Crick
base pairs to their targets but by forming complex 3D shapes
that are responsible for their behavior. For example, RNA struc-
ture can be dramatically affected by temperature, and there now
are numerous examples of UTRs of mRNAs that function as RNA
thermometers to control gene expression in response to temper-
ature change (Kortmann and Narberhaus, 2012). RNA also can
form shapes that recognize various proteins, either to modulate
protein function or to serve as landing sites for gene control fac-
tors. An example of the former is 6S RNA, which is a mimic of an
open DNA promoter complex and inhibits RNA transcription by
decoying RNA polymerase to bind the structured RNA rather
than engaging the promoter (Cavanagh and Wassarman,
2014). Examples of the latter occur in the 50-UTR of mRNAs for
ribosomal proteins, binding the protein product of the adjacent
coding region as a form of feedback control (Deiorio-Haggar
et al., 2013). Other complex folded RNAs from bacteria, termed
‘‘riboswitches,’’ are discussed in the next section.
In eukaryotes, an even greater fraction of the genome appears
to give rise to ncRNAs. Some of these, such as microRNAs
(Ameres and Zamore, 2013) and PIWI-interacting RNAs (Luteijn
and Ketting, 2013), are very small and function as targeting sys-
tems in a manner analogous to CRISPR RNAs. Long intergenic
ncRNAs (lincRNAs) (Ulitsky and Bartel, 2013) are a large and
more mysterious collection of transcripts. Currently very little is
known about these RNAs, causing some researchers to believe
that many are simply the result of transcriptional noise, although
others clearly have important biological functions in chromatin
remodeling and DNAmodification. The most extensively studied
RNA of this type is Xist (Chalingne´ and Heard, 2014), which is
essential for silencing most genes on one of the two X chromo-
somes of human females. The opportunities for exploration of
eukaryotic lincRNA structure and function are substantial and
will require considerable ingenuity in devising new approaches
in RNA chemical biology.
From Aptamer to Aptazyme to Riboswitch
Someone new to the field of RNA research might question why
speculation in the 1960s regarding RNA function was consid-
ered so bold at the time. Now with many recognized examples
of complex RNA structures and functions in biology, the field
readily embraces each newly discovered ncRNA and ponders
its potential relevance to ancient RNAs. However, even in the
early 1990s, when much evidence was in hand that RNA can
adopt complex structures and carry out sophisticated cata-
lytic functions, considerable doubt remained whether RNA
could accomplish much on its own, without the assistance of
proteins.
These doubts about the functional capacity of RNA were
greatly reduced when chemical biologists began to apply
in vitro evolution methods to expand the boundaries of known
nucleic-acid-based function (Wilson and Szostak, 1999; Joyce,
2004). Chemistry & Biology was launched in the midst of this
technological revolution and became a major publisher of the
discoveries that emerged. In vitro evolution uses populations
of trillions of different RNA or DNAmolecules that are challenged
to perform a chemical task, for example, cleave DNA (Robertson1060 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltand Joyce, 1990) or selectively bind a small molecule or protein
target (Ellington and Szostak, 1990; Tuerk and Gold, 1990).
In vitro evolution strategies also were used to develop
numerous RNAs and DNAs that form selective, high-affinity
binding pockets (aptamers) for compounds ranging from drugs
to fundamental metabolites (Osborne and Ellington, 1997).
Many influential advances in aptamer science have been
described in Chemistry & Biology, helping reveal more about
the scope of RNA function. The isolation of RNAs that bind ami-
noglycoside antibiotics demonstrated that RNA can adopt
diverse architectures to recognize members of this important
drug class (Lato et al., 1995). The first detailed analyses of ap-
tamer structure at atomic resolution began to reveal how nucleic
acids can form binding pockets for highly diverse small molecule
ligands (Feigon et al., 1996; Jiang et al., 1997; Lin and Patel,
1997). Through this work, chemical biologists spearheaded the
study of RNA-ligand interactions, well in advance of the discov-
eries of most natural aptamers. Even mirror-image aptamers
(termed ‘‘Spiegelmers’’) were created using in vitro evolution,
first by conducting a conventional selection against the enan-
tiomer of the target, then preparing the resulting aptamers as
L-RNA or L-DNA molecules that bind the desired target (Leva
et al., 2002).
An interesting technological advance, both for nature and for
chemical biologists, comes from the fusion of aptamer and ribo-
zyme functionality. Although creatures of the RNA World may
have invented RNA switches billions of years ago (Breaker,
2011), chemical biologists were the first scientists to demon-
strate the potential for ligand-triggered switches constructed of
either RNA or DNA. For example, by judiciously fusing an ATP
aptamer to a structurally sensitive portion of the hammerhead ri-
bozyme, RNA self-cleavage wasmade to be strongly dependent
on the presence of ATP (Tang and Breaker, 1997). A similar ATP-
responsive system was constructed using DNA (Levy and Elling-
ton, 2002).
These aptamer-ribozyme constructs were investigated mostly
for their intrinsic interest and for potential application as either
chemical sensors (Srinivasan et al., 2004) or engineered gene
control elements (Soukup and Breaker, 1999). Therefore it
came as somewhat of a surprise when, only 5 years after the first
engineered allosteric ribozyme was described, the first validated
examples of riboswitches in modern cells were published (Nahvi
et al., 2002). To date, more than 30 different classes of ribo-
switches are known to exist in nature (Breaker, 2011), and
certainly many more are waiting to be discovered.
Because the aptamer domain of riboswitches can be occu-
pied by ligand analogs, these regulatory elements are intriguing
targets for potential therapeutic agents (Sudarsan et al., 2005;
Blount and Breaker, 2006; Deigan and Ferre´-D’Amare´, 2011).
Researchers are taking various approaches to develop com-
pounds that affect riboswitch function, including designing
analogs of existing ligands (Mulhbacher et al., 2010) and using
high-throughput or fragment-based screening approaches
(Mayer and Famulok, 2006; Warner et al., 2014).
Most natural riboswitches do not control ribozyme activity,
instead undergoing structural rearrangement upon ligand bind-
ing that affects various components of gene expression sys-
tems, including RNA polymerases, ribozymes, and transcription
factors. However, a few cases of natural allosteric ribozymesd All rights reserved
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Figure 1. A Sophisticated RNA Device
(A) Arrangement of aptamer and ribozyme do-
mains within a naturally occurring allosteric self-
splicing group I ribozyme. The aptamer senses the
bacterial second messenger c-di-GMP, and the
ribozyme requires guanosine or one of its phos-
phorylated derivatives (e.g., GTP) as a substrate to
initiate the first step of splicing. ORF, open reading
frame; ss, splice site.
(B) Key sequence and secondary structural
elements within the allosteric switch. Binding of
c-di-GMP to the aptamer domain stabilizes the
aptamer P1 stem, which permits formation of the
ribozyme P1stem, thereby enabling splicing initi-
ated by GTP attack at the 50 splice site (GTP-1).
This configuration allows translation of the down-
stream ORF. In the absence of c-di-GMP, alter-
native pairing (blue shading) precludes formation
of the ribozymeP1 stem and allows formation of an
alternative ribozyme stem (green shading). This
promotes GTP to attack at a position far down-
stream of the normal 50 splice site (GTP-2), thus
preventing translation of the downstream ORF.
Figure adapted from Lee et al. (2010).
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Clostridium difficile, in which a riboswitch contains an aptamer
domain for the signaling compound c-di-GMP, which in turn
regulates self-splicing by a group I ribozyme (Lee et al., 2010;
Chen et al., 2011) (Figure 1). This represents one of the most
complex all-RNA devices yet discovered and hints at the possi-
bility that other complex RNA systems might exist among the
vast number of RNAs of unknown function that are present in
modern cells.
DNA Can Be an Enzyme Too
In the fall of 1994, we were attempting to develop an improved
version of the self-cleaving hammered ribozyme, using in vitro
selection to obtain variants with enhanced catalytic rate. The se-
lection scheme involved tethering randomized forms of the
hammerhead to a short substrate domain, which was immobi-
lized on a solid support. The expectation was that those variants
best able to bring about cleavage would preferentially detach
themselves from the support and be selectively amplified. It
wasn’t going well, because of the substantial background levelChemistry & Biology 21, September 18, 2014 ªof nonspecific cleavage throughout the
molecule. If only the rest of the molecule
weren’t so susceptible to cleavage. If
only it were constructed of DNA.
The same oligonucleotides that were
being used to construct the population
of variant RNAs were repurposed to
construct random-sequence DNAs that
were linked by a single susceptible ribo-
nucleotide to a solid support. We feared
that if we provided more than one ribo-
nucleotide, the catalytic motif would
arise from that segment of RNA rather
than lowly DNA. Within a period of
5 days, the first DNA enzyme was
born. The simple motif consists of two
substrate-binding arms that flank a cata-lytic center of 15 residues, catalyzing the Pb2+-dependent
cleavage of an RNA phosphodiester with a rate enhancement
of 105-fold compared with the uncatalyzed reaction. At that
time, and still today, there are no known evolved DNA enzymes
in biology. This was a chemist’s creation based on the princi-
ples of evolutionary biology and biochemistry. Naturally, the
paper was published in Chemistry & Biology (Breaker and
Joyce, 1994).
Other DNA enzymes soon followed, including a DNA enzyme
that catalyzes the joining of imidazole-activated oligodeoxynu-
cleotides (Cuenoud and Szostak, 1995), a DNA enzyme that
catalyzes the Mg2+-dependent cleavage of an RNA phospho-
diester (Breaker and Joyce, 1995), and a general-purpose
RNA-cleaving DNA enzyme that can be directed to cleave a
wide variety of target RNAs under physiological conditions
(Santoro and Joyce, 1997). The latter of these, termed the
‘‘10-23’’ DNA enzyme, has been made to cleave c-jun mRNA
in cells (Cai et al., 2012) and recently completed a successful
phase I/IIa human clinical trial for the treatment of basal cell car-
cinoma (Cho et al., 2013).2014 Elsevier Ltd All rights reserved 1061
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certainly occupy the highest place. RNA enzymes come next
because of their role in biology, most notably the ribosome,
but also the many remarkable RNA enzymes that have been ob-
tained by in vitro evolution (see below). DNA has its place as well,
now with more than 20 examples of DNA enzymes that catalyze
diverse chemical transformations. These include the phosphory-
lation (Li and Breaker, 1999), ligation (Sreedhara et al., 2004), de-
glycosylation (Sheppard et al., 2000), and hydrolytic cleavage
(Chandra et al., 2009) of DNA substrates, as well as reactions
involving non-nucleic-acid substrates, such as porphyrin metal-
lation (Li and Sen, 1996), Diels-Alder cycloaddition (Chandra and
Silverman, 2008), and tyrosine phosphorylation (Walsh et al.,
2013).
In retrospect, it does not seem surprising that DNA can be an
enzyme, given the immense combinatorics of possible DNA se-
quences and the power of Darwinian evolution to discover and
refine those sequences that give rise to structure and function.
There continues to be a sense that RNA is a more versatile cata-
lyst than DNA, but RNA and DNA are fraternal twins, with
different personalities yet highly similar composition. More sur-
prising is that, 20 years after the discovery of DNA enzymes,
no new class of evolved macromolecular catalyst has been re-
ported. One cannot count chemically modified RNA and DNA,
although there are several examples of nucleic acid enzymes
that contain modified bases (Wiegand et al., 1997; Tarasow
et al., 1997; Santoro et al., 2000; Lermer et al., 2002) or carry a
substitution at the C20-position (Beaudry et al., 2000). Recent ad-
vances with ‘‘xeno nucleic acids’’ (XNAs), which contain a back-
bone other than (deoxy)ribose-phosphate, appear promising
and have already led to the development of XNA aptamers (Yu
et al., 2012; Pinheiro et al., 2012). One can confidently predict
that the first XNAzyme soon will be reported.
Pushing the Frontiers of RNA Catalysis
Many seminal discoveries pertaining to RNA catalysis have been
described inChemistry & Biology (Figure 2). It turns out that Crick
underestimated the ability of RNA to catalyze the aminoacylation
of tRNA. Suga and colleagues used in vitro evolution to obtain a
45-nucleotide RNA that charges the 30-hydroxyl of tRNA with
various activated amino acids (Saito et al., 2001; Murakami
et al., 2003). An analog of the peptidyltransferase reaction also
has been carried out using an in vitro evolved RNA enzyme
(Zhang and Cech, 1997; Zhang and Cech, 1998). Several classic
reactions of organic synthesis have been catalyzed by in vitro
evolved RNAs, including Diels-Alder cycloaddition (Seelig and
Ja¨schke, 1999), Michael addition (Sengle et al., 2001), and aldol
condensation (Fusz et al., 2005), all of which were reported in
Chemistry & Biology.
Chemical biologists have various motivations for developing
novel RNA enzymes. One goal is to explore the catalytic potential
of RNA and to understand how RNA structure gives rise to func-
tion. There are only a few known examples of RNA enzymes in
biology and, other than the ribosome, all of these catalyze phos-
phodiester cleavage or ligation reactions. Although more natu-
rally occurring ribozymes are likely to be discovered, biological
catalysis is overwhelmingly dominated by protein enzymes. Pro-
tein enzymologists can feast upon these diverse examples to
study the relationships among sequence, structure, and func-1062 Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Lttion. RNA enzymologists are forced to take matters into their
own hands and construct their own examples, drawing on the
methods of in vitro evolution. There is added value in exploring
the evolutionary process itself. One can literally track the evolu-
tionary maturation of an enzyme, observing its phylogeny at the
molecular level, including the range of permissible sequence
variation.
Other motivations for developing novel RNA enzymes are
more practical, for example, to provide tools for chemical syn-
thesis, modification of biological molecules, construction of
biomaterials, detection of target ligands, and therapeutic appli-
cations. These goals place additional demands on the per-
formance of the RNA enzymes: that they be small, stable, fast,
specific, and amenable to a desired set of reaction conditions;
preferably all of the above. Seeking to meet those demands
further drives the understanding of the limits of RNA catalysis.
There are some tasks that seem out of reach for RNA, such as
controlling free radical chemistry, derivatizing linear alkanes,
and operating in nonaqueous solvents. Yet one should not be
surprised if some of these ‘‘insurmountable’’ challenges have
been achieved by the 40th anniversary of Chemistry & Biology.
Greater use of catalytic cofactors likely will be beneficial in this
regard. RNA has a remarkable ability to bind and position other
compounds, which in turn could do the heavy lifting of catalysis.
After all, this is what proteins do to augment the functionality of
their RNA creators.
Finally, there is the invention of life itself, which is widely
thought to have been brought about by RNA. RNA is adept at
catalyzing the RNA-dependent polymerization of RNA, what
Crick regarded as the first enzymatic function of life. There are
many examples of in vitro evolved RNA enzymes that catalyze
the RNA-templated ligation of RNA. One of these, the class I
RNA ligase (Bartel and Szostak, 1993), has been through a
remarkable journey of evolutionary development over the past
two decades. It has been evolved to polymerize nucleoside tri-
phosphates, at first just a few (Ekland and Bartel, 1996), then a
full turn of the helix (Johnston et al., 2001), then several turns
(Wochner et al., 2011), and now more than the length of the
RNA enzyme itself (Attwater et al., 2013). Another RNA ligase
has been configured so that it can produce additional copies
of itself (Paul and Joyce, 2002) and undergo self-sustained
Darwinian evolution (Lincoln and Joyce, 2009). Earlier this year
a turbocharged version of this self-replicating enzyme was re-
ported (Robertson and Joyce, 2014), with a doubling time of
only 5 min and able to achieve 10100-fold amplification in
37.5 hr.
Can life itself be constructed in the laboratory based on RNA
enzymes? If one were able to combine the best properties of
the existing RNA polymerase and RNA replicase enzymes,
then perhaps so. Then the self-evolving system would have
the opportunity to explore the frontiers of RNA catalysis for
its own selective advantage. Chemists who set those wheels
in motion would become neobiologists, spectators, and inter-
preters of a new biology. Other chemists would pounce on
that new biology as a source of natural products, targets for
discovery and manipulation, and new opportunities to probe
RNA structure and mechanism. It sounds like it would be a
great time to be a chemical biologist, as it has been for the
past 20 years.d All rights reserved
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Figure 2. What Do These RNAs Have in Common?
All are in vitro evolved ribozymes that catalyze biologically relevant chemical transformations, and all were published in Chemistry & Biology.
(A) The ‘‘39M38tr’’ ribozyme, which catalyzes Diels-Alder cycloaddition between biotin maleamide and anthracene that is tethered to the 50 end of the ribozyme
via an alkyl linker (Seelig and Ja¨schke, 1999).
(B) The ‘‘Fx3 (flexizyme)’’ ribozyme, which catalyzes 30-aminoacylation of tRNA using the cyanomethyl ester of phenylalanine or other amino acids (Murakami
et al., 2003).
(C) The ‘‘UV5’’ ribozyme,whichcatalyzesMichael additionbetweenbiotin cysteine and fumaramide that is tethered to the50 endof the ribozyme (Sengle et al., 2001).
(D) The ‘‘11D2’’ ribozyme, which catalyzes aldol condensation between biotin-linked benzaldehyde-4-carboxamide and levulinic amide that is tethered to the 50
end of a separate oligonucleotide (Fusz et al., 2005).
(E) The ‘‘R180’’ ribozyme, which catalyzes peptide bond formation between an aminoacyl 50-adenylate and an amino acid that is tethered to the 50 end of the
ribozyme via a disulfide linkage (Zhang and Cech, 1998; Sun et al., 2002).
Curved arrow indicates the site of reaction. Circled B indicates a biotin moiety.
Chemistry & Biology 21, September 18, 2014 ª2014 Elsevier Ltd All rights reserved 1063
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